XML 50 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment reporting (Tables)
 9 Months Ended
May 31, 2018
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three months ended May 31, 2018
 
 
 
 
 
 
 
 
 
Sales to external customers
$
25,917

 
$
2,995

 
$
5,422

 
$
—

 
$
34,334

Intersegment sales
—

 
—

 
543

 
(543
)
 
—

Sales
$
25,917

 
$
2,995

 
$
5,965

 
$
(543
)
 
$
34,334

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,492

 
$
198

 
$
257

 
$
—

 
$
1,947

 
 
 
 
 
 
 
 
 
 
Three months ended May 31, 2017
 

 
 

 
 

 
 

 
 

Sales to external customers
$
22,528

 
$
2,809

 
$
4,781

 
$
—

 
$
30,118

Intersegment sales
—

 
—

 
515

 
(515
)
 
—

Sales
$
22,528

 
$
2,809

 
$
5,296

 
$
(515
)
 
$
30,118

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,463

 
$
193

 
$
253

 
$
5

 
$
1,914

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Nine months ended May 31, 2018
 
 
 
 
 
 
 
 
 
Sales to external customers
$
72,884

 
$
9,395

 
$
15,816

 
$
—

 
$
98,095

Intersegment sales
—

 
—

 
1,622

 
(1,622
)
 
—

Sales
$
72,884

 
$
9,395

 
$
17,438

 
$
(1,622
)
 
$
98,095

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
4,518

 
$
688

 
$
712

 
$
1

 
$
5,919

 
 
 
 
 
 
 
 
 
 
Nine months ended May 31, 2017
 
 
 
 
 
 
 
 
 
Sales to external customers
$
65,001

 
$
8,872

 
$
14,192

 
$
—

 
$
88,065

Intersegment sales
—

 
—

 
1,551

 
(1,551
)
 
—

Sales
$
65,001

 
$
8,872

 
$
15,743

 
$
(1,551
)
 
$
88,065

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
4,304

 
$
648

 
$
703

 
$
1

 
$
5,656
Reconciliation of Operating Income (Loss) from Segments to Consolidated
The following table reconciles adjusted operating income to operating income (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three months ended May 31, 2018
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,492

 
$
198

 
$
257

 
$
—

 
$
1,947

Acquisition-related amortization
 

 
 

 
 

 
 

 
(131
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(57
)
LIFO provision
 

 
 

 
 

 
 

 
(69
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(60
)
Certain legal and regulatory accruals and settlements
 

 
 

 
 

 
 

 
(5
)
Store optimization
 
 
 
 
 
 
 
 
(24
)
Operating income
 

 
 

 
 

 
 

 
$
1,601

 
 
 
 
 
 
 
 
 
 
Three months ended May 31, 2017
 

 
 

 
 

 
 

 
 

Adjusted operating income
$
1,463

 
$
193

 
$
253

 
$
5

 
$
1,914

Acquisition-related amortization
 

 
 

 
 

 
 

 
(83
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(29
)
LIFO provision
 

 
 

 
 

 
 

 
(97
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(17
)
Cost transformation
 
 
 
 
 
 
 
 
(171
)
Operating income
 

 
 

 
 

 
 

 
$
1,517

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Nine months ended May 31, 2018
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
4,518

 
$
688

 
$
712

 
$
1

 
$
5,919

Acquisition-related amortization
 

 
 

 
 

 
 

 
(329
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(173
)
LIFO provision
 

 
 

 
 

 
 

 
(166
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(136
)
Certain legal and regulatory accruals and settlements
 

 
 

 
 

 
 

 
(120
)
Hurricane-related costs
 
 
 
 
 
 
 
 
(83
)
Store optimization
 
 
 
 
 
 
 
 
(24
)
Asset recovery
 
 
 
 
 
 
 
 
15

Operating income
 

 
 

 
 

 
 

 
$
4,903

 
 
 
 
 
 
 
 
 
 
Nine months ended May 31, 2017
 

 
 

 
 

 
 

 
 

Adjusted operating income
$
4,304

 
$
648

 
$
703

 
$
1

 
$
5,656

Acquisition-related amortization
 

 
 

 
 

 
 

 
(247
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(75
)
LIFO provision
 

 
 

 
 

 
 

 
(204
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(95
)
Cost transformation
 

 
 

 
 

 
 

 
(592
)
Operating income
 

 
 

 
 

 
 

 
$
4,443